NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

Despite rebukes by two federal circuit courts, an HHS sub-agency continues to overstep its authority when administering a ...

Johnson & Johnson sued the U.S. Health and Human Services Department on Tuesday, accusing the agency of blocking its plan to ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Johnson & Johnson is escalating its fight with the federal government over its controversial plan to change how it doles out ...

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug ...

The antitrust regulator said Wednesday it has imposed fines worth 300 million won (US$213,000) on Jeil Pharmaceutical Co., a ...

now the second-largest federal drug initiative after Medicare, has been exploited by entities not intended initially as ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Consider one practice that illustrates the problem before Congress: PBMs aggressively negotiate large rebates from drug companies. These rebates dramatically cut insurance companies’ costs for ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Johnson & Johnson is challenging a federal health agency for blocking its plan to discount drugs through a rebate model ...